Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645666.RAniw8fTBXXEoewkznGkoQvzyshBXGiceVJdCV4d2j-GE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645666.RAniw8fTBXXEoewkznGkoQvzyshBXGiceVJdCV4d2j-GE130_assertion type Assertion NP645666.RAniw8fTBXXEoewkznGkoQvzyshBXGiceVJdCV4d2j-GE130_head.
- NP645666.RAniw8fTBXXEoewkznGkoQvzyshBXGiceVJdCV4d2j-GE130_assertion description "[There was also no effect in a subgroup of patients on carbamazepine, which is thought to be a RLIP76 substrate, although two polymorphisms were associated with time to first seizure (p = 0.007).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645666.RAniw8fTBXXEoewkznGkoQvzyshBXGiceVJdCV4d2j-GE130_provenance.
- NP645666.RAniw8fTBXXEoewkznGkoQvzyshBXGiceVJdCV4d2j-GE130_assertion evidence source_evidence_literature NP645666.RAniw8fTBXXEoewkznGkoQvzyshBXGiceVJdCV4d2j-GE130_provenance.
- NP645666.RAniw8fTBXXEoewkznGkoQvzyshBXGiceVJdCV4d2j-GE130_assertion SIO_000772 18086001 NP645666.RAniw8fTBXXEoewkznGkoQvzyshBXGiceVJdCV4d2j-GE130_provenance.
- NP645666.RAniw8fTBXXEoewkznGkoQvzyshBXGiceVJdCV4d2j-GE130_assertion wasDerivedFrom befree-2016 NP645666.RAniw8fTBXXEoewkznGkoQvzyshBXGiceVJdCV4d2j-GE130_provenance.
- NP645666.RAniw8fTBXXEoewkznGkoQvzyshBXGiceVJdCV4d2j-GE130_assertion wasGeneratedBy ECO_0000203 NP645666.RAniw8fTBXXEoewkznGkoQvzyshBXGiceVJdCV4d2j-GE130_provenance.